Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

Until last year, the number of children orphaned because a parent died from AIDS, was plummeting. That's thanks to America's 20 year effort to get lifesaving HIV meds to millions in need. But last ...

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...

Luke Davis, 31, from Kidderminster, was convicted of inflicting grievous bodily harm on the victim after failing to disclose ...

Luke Davis, 31, found guilty of inflicting grievous bodily harm on woman whom he did not tell about diagnosis ...

Science progresses when people share what they learn, not when they retreat behind borders or institutions. That was true when my colleagues and I first discovered a protein, known today as ...